Brain Imaging Study of F17464

Pierre Fabre

Status and phase: Completed; Phase 1

Conditions: Healthy Volunteers

Treatments: Drug: F17464

Study type: Interventional

Funder types: Industry

Identifiers

NCT01689038

F17464 PO 1 02

Details and patient eligibility

About

Assess the binding rate of F17464 to cerebral receptors in healthy volunteers.

Enrollment: 8 patients

Sex: Male

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Male healthy volunteers

Exclusion criteria

• Presence or positive history of severe medical illness or psychiatric conditions

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

8 participants in 1 patient group

Tested product

Experimental group

Treatment:

Drug: F17464